Gengos Andrew

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$243,017.22
Insider Sells Quantity
3
Insider Sells Sum
$7,750.51

Insider Activity of Gengos Andrew

According to the SEC Form 4 filings, Gengos Andrew, being in a position of

  1. CFO and Chief Business Officer at Athira Pharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2480 shares for $4,235,
    over all time since 2023-01-05, has bought 80012 shares for $243,017, and sold 3688 shares for $7,751.

The largest purchase of all time was on 2023-06-05 and amounted to 45000 shares of Athira Pharma, Inc. for $135,150.

The largest sale of all time was on 2023-01-05 and amounted to 1208 shares of Athira Pharma, Inc. for $3,515.

Biography of Gengos Andrew

No biography is available at this moment.

2024-09-05SaleAthira Pharma, Inc.
ATHA
CFO and Chief Business Officer
1,272
0.0033%
$0.57$720-20.07%
2024-01-05SaleAthira Pharma, Inc.
ATHA
CFO AND CHIEF BUSINESS OFFICER
1,208
0.0032%
$2.91$3,515-11.15%
2023-06-07PurchaseAthira Pharma, Inc.
ATHA
See Below
15,000
0.0378%
$3.43$51,445-29.8%
2023-06-05PurchaseAthira Pharma, Inc.
ATHA
See Below
45,000
0.1184%
$3.00$135,150-16.28%
2023-06-02PurchaseAthira Pharma, Inc.
ATHA
See Below
20,012
0.0493%
$2.82$56,422-16.56%
2023-01-05SaleAthira Pharma, Inc.
ATHA
See Below
1,208
0.0027%
$2.91$3,515
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.